
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 193 pages)
“Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis”, CNS Drugs, vol. 29, pp. 591-603, 2015.
, “The association between thyroid disorders and incident gout: population-based case-control study”, Clin Epidemiol, vol. 9, pp. 205-215, 2017.
, “Association of hormone therapy and incident gout: population-based case-control study”, Menopause, vol. 22, pp. 1335-42, 2015.
, “Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis”, Drug Saf, vol. 38, pp. 909-19, 2015.
, “Case-control analysis on metformin and cancer of the esophagus”, Cancer Causes Control, vol. 24, pp. 1763-70, 2013.
, “Colorectal cancer and markers of anemia”, Eur J Cancer Prev, vol. 27, pp. 530-538, 2018.
, “Diabetes mellitus and the risk of cholecystectomy”, Dig Liver Dis, vol. 43, pp. 742-7, 2011.
, “Diabetes, use of antidiabetic drugs, and the risk of glioma”, Neuro Oncol, vol. 18, pp. 340-9, 2016.
, “The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK”, J Invest Dermatol, vol. 137, pp. 1240-1247, 2017.
, “Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK–a nested case-control analysis”, Diabetes Obes Metab, vol. 16, pp. 801-11, 2014.
, “Lifestyle factors, psychiatric and neurologic comorbidities, and drug use associated with incident seizures among adult patients with depression: a population-based nested case-control study”, Eur J Epidemiol, vol. 31, pp. 1113-1122, 2016.
, “Long-term metformin use is associated with decreased risk of breast cancer”, Diabetes Care, vol. 33, pp. 1304-8, 2010.
, “Metformin and the risk of endometrial cancer: a case-control analysis”, Gynecol Oncol, vol. 129, pp. 565-9, 2013.
, “Metformin and the risk of head and neck cancer: a case-control analysis”, Diabetes Obes Metab, vol. 16, pp. 1148-54, 2014.
, “Metformin and the risk of renal cell carcinoma: a case-control analysis”, Eur J Cancer Prev, vol. 26, pp. 257-262, 2017.
, “Metformin does not alter the risk of lung cancer: a case-control analysis”, Lung Cancer, vol. 78, pp. 133-7, 2012.
, “Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study”, J Am Geriatr Soc, vol. 60, pp. 916-21, 2012.
, “No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study”, BMC Cancer, vol. 15, p. 719, 2015.
, “Poorly controlled type 2 diabetes mellitus is associated with a decreased risk of incident gout: a population-based case-control study”, Ann Rheum Dis, vol. 74, pp. 1651-8, 2015.
, “Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis”, Drug Saf, vol. 41, pp. 1387-1396, 2018.
, “Risk of incident stroke in patients with Alzheimer disease or vascular dementia”, Neurology, vol. 81, pp. 910-9, 2013.
, “Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case-Control Analysis Using the Clinical Practice Research Datalink”, Drug Saf, vol. 39, pp. 307-21, 2016.
, “The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs”, Epilepsia, vol. 58, pp. 2178-2185, 2017.
, “Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis”, Epilepsia, vol. 54, pp. 700-7, 2013.
, “Statin use and risk of gallstone disease followed by cholecystectomy”, Jama, vol. 302, pp. 2001-7, 2009.
, “Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis”, Am J Gastroenterol, vol. 107, pp. 620-6, 2012.
, “Use of diuretics and risk of incident gout: a population-based case-control study”, Arthritis Rheumatol, vol. 66, pp. 185-96, 2014.
, “Use of metformin and the risk of ovarian cancer: a case-control analysis”, Gynecol Oncol, vol. 123, pp. 200-4, 2011.
, “Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis”, Cancer Epidemiol Biomarkers Prev, vol. 21, pp. 280-6, 2012.
, “Use of thiazolidinediones and fracture risk”, Arch Intern Med, vol. 168, pp. 820-5, 2008.
, “Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 429-436, 2017.
,